---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-014828"
form_type: "8-K"
ticker: "CBIO"
cik: "0001253689"
company_name: "CRESCENT BIOPHARMA, INC."
filed_at: "2022-10-04T23:59:59+00:00"
generated_at: "2026-06-23T05:30:58.059362+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# GlycoMimetics files 8-K with slide presentation for investor meetings; content not disclosed

## Summary
- Slide presentation furnished as Exhibit 99.1 for investor meetings on October 4, 2022.
- No financial or clinical data from the presentation is included in this filing.
- The presentation is provided under Regulation FD and is not deemed filed for SEC purposes.

## SEC filing metadata
- accession: 0001558370-22-014828
- form_type: 8-K
- ticker: CBIO
- cik: 0001253689
- company_name: CRESCENT BIOPHARMA, INC.
- filed_at: 2022-10-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1253689/000155837022014828/0001558370-22-014828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1253689/000155837022014828/glyc-20221004x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-014828
- JSON: https://secwatch.observer/filing/0001558370-22-014828.json
- Plain text: https://secwatch.observer/filing/0001558370-22-014828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.